Hospital costs of acute pulmonary embolism

American Journal of Medicine

Volumn 126, Issue 2, 2013, Pages 127-132

  Fanikos, John ^a   Rao, Amanda ^a   Seger, Andrew C ^a   Carter, Danielle ^a   Piazza, Gregory ^a   Goldhaber, Samuel Z ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Economics; Hospital cost; Pulmonary embolism; Venous thromboembolism

Indexed keywords

FONDAPARINUX; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; THROMBIN INHIBITOR; TROPONIN; WARFARIN;

ANTICOAGULANT THERAPY; ARTICLE; CANCER PATIENT; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; COST BENEFIT ANALYSIS; DEEP VEIN THROMBOSIS; ECHOCARDIOGRAPHY; HOSPITAL ADMISSION; HOSPITAL COST; HOSPITAL PATIENT; LENGTH OF STAY; LUNG ANGIOGRAPHY; LUNG EMBOLISM; MORTALITY; NURSING CARE; OBESITY; PHARMACY; PRESCRIPTION; PRIORITY JOURNAL; RADIOLOGY; SURGERY; THORAX RADIOGRAPHY;

ACUTE DISEASE; AGED; ANTICOAGULANTS; DRUG COSTS; ECONOMICS, NURSING; FEMALE; HOSPITAL COSTS; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PULMONARY EMBOLISM;

EID: 84872523072     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2012.07.025     Document Type: Article

References (33)

1. C.E. Mahan, M.T. Holdsworth, S.M. Welch Deep vein thrombosis: a United States cost model for a preventable and costly adverse event Thromb Haemost 106 2011 405 415
2. P.P. Dobesh Economic burden of venous thromboembolism in hospitalized patients Pharmacotherapy 29 2009 943 953
3. B. Park, L. Messina, P. Dargon Recent trends in clinical outcomes and resource utilization for pulmonary embolism in the United States Findings from the Nationwide Inpatient Sample Chest 136 2009 983 990
4. N. Kucher, S. Koo, R. Quiroz Electronic alerts to prevent venous thromboembolism among hospitalized patients N Engl J Med 352 2005 969 977
5. G. Piazza, E. Rosenbaum, W. Pendergast Physician alerts to prevent symptomatic venous thromboembolism in hospitalized patients Circulation 119 2009 2196 2201
6. G. Piazza, T.N. Nguyen, R. Morrison Patient education program for venous thromboembolism prevention in hospitalized patients Am J Med 125 2012 258 264
7. M.F. Bullano, V. Willey, O. Hauch Longitudinal evaluation of health plan cost per venous thromboembolism or bleed event in patients with a prior venous thromboembolism event during hospitalization Am J Manag Care Pharm 11 2005 663 673
8. A.C. Spyropoulos, J. Lin Direct medical costs of venous thromboembolism and subsequent hospital readmission rates: an administrative claims analysis from 30 managed care organizations J Manag Care Pharm 13 2007 475 486
9. D. Aujesky, P.M. Roy, F. Verschuren Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomized, non-inferiority trial Lancet 378 2011 41 48
10. M.J. Agterof, R.E. Schutgens, R.J. Snijder Out of hospital treatment of acute pulmonary embolism in patients with a low NT-proBNP level J Thromb Haemost 8 2010 1235 1241
11. P.M. Erkens, E. Gandara, P. Wells Safety of outpatient treatment in acute pulmonary embolism J Thromb Haemost 8 2010 2412 2417
12. M.J. Kovacs, J.D. Hawel, J.F. Rekman, A. Lazo-Langner Ambulatory management of pulmonary embolism: a pragmatic evaluation J Thromb Haemost 8 2010 2406 2411
13. S. Siragusa, C. Arcara, A. Malato Home therapy for deep vein thrombosis and pulmonary embolism in cancer patients Ann Oncol 16 2005 iv136 iv139
14. J.H. Beer, M. Burger, S. Gretener Outpatient treatment of pulmonary embolism is feasible and safe in a substantial proportion of patients J Thromb Haemost 1 2003 186 187
15. M.J. Kovacs, D. Anderson, B. Morrow Outpatient treatment of pulmonary embolism with dalteparin Thromb Haemost 83 2000 209 211
16. P.S. Wells, D.R. Anderson, M.A. Rodger A randomized trial comparing 2 low-molecular-weight heparins for the outpatient treatment of deep vein thrombosis and pulmonary embolism Arch Intern Med 165 2005 733 738
17. D. Aujesky, R.A. Stone, S. Kim Length of hospital stay and postdischarge mortality in patients with pulmonary embolism A statewide perspective Arch Intern Med 168 2008 706 712
18. C. Kearon, E.A. Akl, A.J. Comerota Antithrombotic therapy for VTE disease Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines Chest 141 2012 e419S e494S
19. The EINSTEIN Investigators Oral rivaroxaban for symptomatic venous thromboembolism N Engl J Med 363 2010 2499 2510
20. The EINSTEIN-PE Investigators Oral rivaroxaban for the treatment of symptomatic pulmonary embolism N Engl J Med 366 2012 1287 1297
21. S. Schulman, C. Kearon, A.J. Kakkar RE-COVER Study Group Dabigatran versus warfarin in the treatment of acute venous thromboembolism N Engl J Med 361 2009 2342 2352
22. U.S. National Institutes of Health Clinical Trials.gov Efficacy and safety study of apixaban for extended treatment of deep vein thrombosis or pulmonary embolism http://www.clinicaltrials.gov/ct2/show/NCT00633893?term= apixaban&rank=12 Accessed June 14, 2012
23. U.S. National Institutes of Health Clinical Trials.gov Comparative investigation of low molecular weight (LMW) heparin/edoxaban tosylate (DU176b) versus (LMW) heparin/warfarin in the treatment of symptomatic deep-vein blood clots and/or lung blood clots (The Edoxaban Hokusai-VTE Study) http://www.clinicaltrials.gov/ct2/show/NCT00986154?term=edoxaban&rank=1 Accessed June 14, 2012
24. C.V. Pollack, D. Schreiber, S.Z. Goldhaber Clinical characteristics, management, and outcomes of patients diagnosed with acute pulmonary embolism in the emergency department Initial report of EMPEROR (Multicenter Emergency Medicine Pulmonary Embolism in the Real World Registry) J Am Coll Cardiol 57 2011 700 706
25. D. Aujesky, D. Jiménez, M.K. Mor Weekend versus weekday admission and mortality after acute pulmonary embolism Circulation 119 2009 962 968
26. F.A. Spencer, D. Lessard, C. Emery Venous thromboembolism in the outpatient setting Arch Intern Med 167 2007 1471 1475
27. A.K. Kakkar, B. Brenner, O.E. Dahl Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial Lancet 373 2008 31 39
28. R.D. Hull, S.M. Schellong, V.F. Tapson EXCLAIM study Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility A randomized trial Ann Intern Med 153 2010 8 18
29. A. Cohen Multicenter, rAndomized, parallel Group Efficacy and safety study for the prevention of VTE in hospitalized acutely iLL medical patients comparing rivaroxabAN with enoxaparin Session 3015 Presented at: American College of Cardiology 60th Annual Scientific Sessions New Orleans, Louisiana April 2-5, 2011
30. S.Z. Goldhaber, A. Leizorovicz, A.K. Kakkar ADOPT Trial Investigators Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients N Engl J Med 365 2011 2167 2177
31. N. Kucher, S.Z. Goldhaber Cardiac biomarkers for risk stratification of patients with acute pulmonary embolism Circulation 108 2003 2191 2194
32. D. Jiménez, D. Aujesky, L. Moores Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism Arch Intern Med 170 2010 1383 1389
33. L.S. Elting, C.P. Escalante, C. Cooksley Outcomes and cost of deep venous thrombosis among patients with cancer Arch Intern Med 164 2004 1653 1661